Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes

J Cell Mol Med. 2020 Aug;24(16):8998-9011. doi: 10.1111/jcmm.15533. Epub 2020 Jun 24.

Abstract

Farnesyltransferase (FTase) is an important enzyme that catalyses the modification of protein isoprene downstream of the mevalonate pathway. Previous studies have shown that the tissue of the heart in the suprarenal abdominal aortic coarctation (AAC) group showed overexpression of FTaseβ (FNTB) and the activation of the downstream protein Ras was enhanced. FTase inhibitor (FTI) can alleviate myocardial fibrosis and partly improve cardiac remodelling in spontaneously hypertensive rats. However, the exact role and mechanism of FTase in myocardial hypertrophy and remodelling are not fully understood. Here, we used recombinant adenovirus to transfect neonatal rat ventricular cardiomyocytes to study the effect of FNTB overexpression on myocardial remodelling and explore potential mechanisms. The results showed that overexpression of FNTB induces neonatal rat ventricular myocyte hypertrophy and reduces the survival rate of cardiomyocytes. FNTB overexpression induced a decrease in mitochondrial membrane potential and increased apoptosis in cardiomyocytes. FNTB overexpression also promotes autophagosome formation and the accumulation of autophagy substrate protein, LC3II. Transmission electron microscopy (TEM) and mCherry-GFP tandem fluorescent-tagged LC3 (tfLC3) showed that FNTB overexpression can activate autophagy flux by enhancing autophagosome conversion to autophagolysosome. Overactivated autophagy flux can be blocked by bafilomycin A1. In addition, salirasib (a Ras farnesylcysteine mimetic) can alleviate the hypertrophic phenotype of cardiomyocytes and inhibit the up-regulation of apoptosis and autophagy flux induced by FNTB overexpression. These results suggest that FTase may have a potential role in future treatment strategies to limit the adverse consequences of cardiac hypertrophy, cardiac dysfunction and heart failure.

Keywords: Farnesyltransferase; MAPK pathway; apoptosis; autophagy; hypertrophy; rat neonatal ventricular cardiomyocytes; recombinant adenovirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / physiology*
  • Autophagic Cell Death / physiology*
  • Autophagosomes / metabolism
  • Autophagosomes / pathology
  • Autophagy / physiology
  • Cardiomegaly / metabolism*
  • Cardiomegaly / pathology
  • Farnesyltranstransferase / metabolism*
  • Heart Failure / metabolism
  • Heart Failure / pathology
  • Heart Ventricles / metabolism
  • Heart Ventricles / pathology
  • Membrane Potential, Mitochondrial / physiology
  • Microtubule-Associated Proteins / metabolism
  • Myocardium
  • Myocytes, Cardiac / metabolism*
  • Myocytes, Cardiac / pathology
  • Rats
  • Rats, Inbred SHR / metabolism
  • Rats, Sprague-Dawley
  • Ventricular Remodeling / physiology
  • ras Proteins / metabolism*

Substances

  • Microtubule-Associated Proteins
  • Farnesyltranstransferase
  • ras Proteins